圣诺生物：2025年半年度归属于上市公司股东的净利润同比增长308.29%

Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance [2] Financial Performance - The company achieved operating revenue of 337,569,910.26 yuan, representing a year-on-year growth of 69.69% [2] - The net profit attributable to shareholders was 88,956,694.45 yuan, showing a remarkable year-on-year increase of 308.29% [2]